Our technology uniquely combines biochemical and physical stimulation of immune cells.
This innovative way of activating immune cells contributes to a significant enhancement of current therapeutic cell production steps, leading to shorter production time and better end product characteristics.
ImmUni is committed to deliver a unique technology to advance cell therapies for benefit of the patients.
Company Details
- Founded
- -
- Address
- Gloriastrasse 37/39, Glc Building,g12.1,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://immuni.ch/
- Keywords
- Regenerative medicine, Drug discovery, Biomechanics, Computational biology, techniques, Science, laboratory, Tissue engineering, Gene therapy, Microbiology, Artificial intelligence, Cell biology, Biopharmaceuticals, Synthetic biology, Virology, Microbiology, Biochemistry, Diagnostic development, Pharmacology.
- HQ
- Stadtkreis 7, Zurich
Immuni Technology Questions
Immuni Technology's website is https://immuni.ch/
Immuni Technology's LinkedIn profile is https://ch.linkedin.com/company/immuni-technology
Immuni Technology's industry is
Biotechnology Research
Immuni Technology's top competitors are
Arcoris Bio Ag,
Ectica Technologies,
Canvirex,
Evax Ag,
Eaglenos Sciences (Switzerland),
Virometix Ag,
Cellec Biotek Ag,
Bucher Biotec Ag,
Selectoprobe,
Precomb.
Immuni Technology's categories are Biotechnology Research
Immuni Technology's founding year is 2023
